(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ENPOINTA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ENPOINTA

ST13

US500000087411884

Class

5

Filing

87411884

Registration

6182384

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

51

Latest update

07/23/2026

Trademark type

Word

Nice classes

5

Filing date

04/14/2017

Registration date

10/27/2020

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/27/2020

Last transaction

07/23/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

99

Owner location

Carrigtohill Co. Cork,, IE

Examiner

HENRY, NAKIA D

Law office

O20

Current location

TMO LAW OFFICE 129 - EXAMINING ATTORNEY ASSIGNED

Holders and representatives

Holders

G. U. (pessoa física)
G. U. (pessoa física)

Representatives

Shelley Lai Gilead Sciences, Inc.

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; anti-fibrotic pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection; pharmaceutical preparations for the treatment of liver diseases and disorders; pharmaceutical preparations for the treatment of hematological diseases and disorders; pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of inflammatory diseases and disorders; pharmaceutical preparations for the treatment of respiratory and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of kidney and nephropathic diseases and disorders; pharmaceutical preparations for the treatment of arthritis

Publications

History of USPTO decisions and trademark events.

51 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

07/22/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

07/22/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

07/22/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

07/22/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

07/22/2026

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

10/27/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/11/2021

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/11/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/11/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/11/2021

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/11/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

10/27/2020

DP1B

1(B) BASIS DELETED; PROCEED TO REGISTRATION

09/23/2020

IUCN

NOTICE OF ALLOWANCE CANCELLED

09/22/2020

D1BR

TEAS DELETE 1(B) BASIS RECEIVED

09/22/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/24/2020

EX5G

SOU EXTENSION 5 GRANTED

03/23/2020

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/23/2020

EXT5

SOU EXTENSION 5 FILED

03/18/2020

EEXT

SOU TEAS EXTENSION RECEIVED

03/18/2020

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/26/2019

EX4G

SOU EXTENSION 4 GRANTED

09/24/2019

EXT4

SOU EXTENSION 4 FILED

09/24/2019

EEXT

SOU TEAS EXTENSION RECEIVED

09/24/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/21/2019

EX3G

SOU EXTENSION 3 GRANTED

03/19/2019

EXT3

SOU EXTENSION 3 FILED

03/19/2019

EEXT

SOU TEAS EXTENSION RECEIVED

03/19/2019

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/15/2018

EX2G

SOU EXTENSION 2 GRANTED

09/13/2018

EXT2

SOU EXTENSION 2 FILED

09/13/2018

EEXT

SOU TEAS EXTENSION RECEIVED

09/13/2018

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/17/2018

EX1G

SOU EXTENSION 1 GRANTED

03/15/2018

EXT1

SOU EXTENSION 1 FILED

03/15/2018

EEXT

SOU TEAS EXTENSION RECEIVED

03/15/2018

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

11/21/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/26/2017

PUBO

PUBLISHED FOR OPPOSITION

09/26/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

09/06/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/21/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

08/21/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

08/21/2017

ALIE

ASSIGNED TO LIE

08/18/2017

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

07/26/2017

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

07/10/2017

GNSL

LETTER OF SUSPENSION E-MAILED

07/10/2017

CNSL

SUSPENSION LETTER WRITTEN

07/10/2017

DOCK

ASSIGNED TO EXAMINER

07/10/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

04/21/2017

NWAP

NEW APPLICATION ENTERED

04/18/2017

Continuous trademark protection

Get notified about every new filing that threatens ENPOINTA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.